294 related articles for article (PubMed ID: 31317522)
1. Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.
Zhang XY; Sun JW; Qiu ZL; Wang Y; Chen XY; Zhao JH; Luo QY
Endocrine; 2019 Nov; 66(2):254-265. PubMed ID: 31317522
[TBL] [Abstract][Full Text] [Related]
2. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
Qiu ZL; Shen CT; Luo QY
Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
[TBL] [Abstract][Full Text] [Related]
3. The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland.
Nixon IJ; Whitcher MM; Palmer FL; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Thyroid; 2012 Sep; 22(9):884-9. PubMed ID: 22827579
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes and Prognoses of Elderly Patients (≥65-Years-Old) With Distant Metastases From Well-Differentiated Thyroid Cancer During Radioiodine Therapy and Follow-Up.
Qiu ZL; Shen CT; Sun ZK; Song HJ; Xi C; Zhang GQ; Wang Y; Luo QY
Front Endocrinol (Lausanne); 2020; 11():588024. PubMed ID: 33716950
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.
Lang BH; Wong KP; Cheung CY; Wan KY; Lo CY
Ann Surg Oncol; 2013 Apr; 20(4):1329-35. PubMed ID: 23104708
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up.
Sohn SY; Kim HI; Kim YN; Kim TH; Kim SW; Chung JH
Clin Endocrinol (Oxf); 2018 Feb; 88(2):318-326. PubMed ID: 28972676
[TBL] [Abstract][Full Text] [Related]
7. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
9. Radioactive iodine refractoriness in Middle Eastern differentiated thyroid cancer: clinical outcome and risk factor analysis.
Parvathareddy SK; Siraj AK; Siraj N; Ahmed SO; Al-Rasheed M; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2024; 15():1326976. PubMed ID: 38812819
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature.
Zhang X; Liu DS; Luan ZS; Zhang F; Liu XH; Zhou W; Zhong SF; Lai H
Clin Transl Oncol; 2018 Jul; 20(7):928-935. PubMed ID: 29119458
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors.
Song HJ; Qiu ZL; Shen CT; Wei WJ; Luo QY
Eur J Endocrinol; 2015 Sep; 173(3):399-408. PubMed ID: 26104753
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.
Sabet A; Binse I; Dogan S; Koch A; Rosenbaum-Krumme SJ; Biersack HJ; Biermann K; Ezziddin S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):190-195. PubMed ID: 27530124
[TBL] [Abstract][Full Text] [Related]
13. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
14. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
Chen P; Feng HJ; Ouyang W; Wu JQ; Wang J; Sun YG; Xian JL; Huang LH
Endocr Pract; 2016 Sep; 22(9):1048-56. PubMed ID: 27124694
[TBL] [Abstract][Full Text] [Related]
15. The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases.
Mihailovic J; Stefanovic L; Malesevic M; Markoski B
Thyroid; 2009 Mar; 19(3):227-32. PubMed ID: 19265493
[TBL] [Abstract][Full Text] [Related]
16. Distant metastases in differentiated thyroid cancer: long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients.
Casara D; Rubello D; Saladini G; Gallo V; Masarotto G; Busnardo B
Tumori; 1991 Oct; 77(5):432-6. PubMed ID: 1781039
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer.
Qiu ZL; Song HJ; Xu YH; Luo QY
J Clin Endocrinol Metab; 2011 Oct; 96(10):3078-86. PubMed ID: 21795449
[TBL] [Abstract][Full Text] [Related]
18. Unusual metastases from differentiated thyroid carcinoma: analysis of 36 cases.
Zunino A; Pitoia F; Faure E; Reyes A; Sala M; Sklate R; Ilera V; Califano I;
Endocrine; 2019 Sep; 65(3):630-636. PubMed ID: 31327159
[TBL] [Abstract][Full Text] [Related]
19. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.
Hirsch D; Levy S; Tsvetov G; Gorshtein A; Slutzky-Shraga I; Akirov A; Robenshtok E; Shimon I; Benbassat CA
Endocr Pract; 2017 Oct; 23(10):1193-1200. PubMed ID: 28704099
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary metastases in children and adolescents with papillary thyroid cancer in China: prognostic factors and outcomes from treatment with
Zhang XY; Song HJ; Qiu ZL; Shen CT; Chen XY; Sun ZK; Wei WJ; Zhang GQ; Luo QY
Endocrine; 2018 Oct; 62(1):149-158. PubMed ID: 30022382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]